OA 15.01 Lung Cancer Screening: Participant Selection by Risk Model – the Pan-Canadian Study
Martin C. Tammemägi(Brock University), S. Lam(Cancer Research Center), Natasha B. Leighl(Princess Margaret Cancer Centre), John C. English(University of British Columbia Hospital), Francis Laberge(Ontario Institute for Cancer Research), Annette McWilliams, Kayvan Amjadi(Ottawa Hospital), G. Liu, Paul MacEachern(University of Calgary), Christian Couture(Institut universitaire de cardiologie et de pneumologie de Québec), Serge Puksa(Juravinski Hospital), Rick Bhatia(St. John's University), Paul Burrowes(University of Calgary), Kazuhiro Yasufuku(University Health Network), John R. Goffin(Juravinski Hospital), Michael Johnston(Statistics New Zealand), Alain Tremblay(Alberta Health Services), Simon Martel(Université du Québec), Jean M. Seely(Ottawa Hospital), Harmanjatinder S. Sekhon(Ottawa Hospital), Daria Manos(Dalhousie University), W.C. Tan, Paola V. Nasute Fauerbach(Queen's University), Ming‐Sound Tsao(Kumamoto University), Frances A. Shepherd(University Health Network), Heidi Schmidt(University Health Network), Stuart Peacock(BC Cancer Agency), Stefan J. Urbanski(University of Calgary), Ehsan Haider(St. Joseph’s Healthcare Hamilton), Glen Goss, Sonya Cressman(BC Cancer Agency), Lesley Stewart(University of York), Garth Nicholas(Ottawa Regional Cancer Foundation), Zhaolin Xu(Dalhousie University), Michel Gingras(Institut universitaire de cardiologie et de pneumologie de Québec), Diana N. Ionescu(BC Cancer Agency), Daehee Hwang(Health Net), John Yee(BC Cancer Agency), DD Sin(University of British Columbia), Colm Boylan(St. Joseph’s Healthcare Hamilton), Richard J. Finley(Vancouver General Hospital), Jean-Claude Cutz, Sen Tien Tsai, Sergio Pasian(Institut universitaire de cardiologie et de pneumologie de Québec), W.K. Evans, Kam Soghrati(University Health Network), J. Mayo(Vancouver Clinic), Sukhinder Atkar-Khattra(BC Cancer Agency)
Cited by 0
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k